{"version":"1.0","type":"link","title":"Resistance mechanisms and post-trastuzumab deruxtecan (T-DXd) strategies in HER2+ and HER2-low breast cancer: From biology to clinical practice.","author_name":"Wen X 외","author_url":"https://prs-insight.online/author/Wen%20X","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/75289","thumbnail_width":1200,"thumbnail_height":630}